Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Synaptogyrin 2 pseudogene 1 (SYNGR2P1) is a processed pseudogene located on chromosome 15q11 in humans[2]. It is homologous to the transmembrane protein-coding gene synaptogyrin 2 (SYNGR2), but does not encode a functional protein. SYNGR2P1 is not known to be transcribed or translated, and no biological or pathological functions have been ascribed to it. Its presence is used primarily as a genomic or evolutionary marker, not as a drug or therapeutic target. SYNGR2P1 is a non-functional pseudogene, not a protein, receptor, or enzyme. It is not a therapeutic or diagnostic target. It is not involved in any recognized biological pathways, disease roles, or drug interactions. Its parent gene, SYNGR2 (Synaptogyrin 2), is functional and involved in membrane trafficking and infection susceptibility[1][4][5], but SYNGR2P1 does not share these properties.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptogyrin 2 pseudogene 1 (SYNGR2P1).